Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

LIN-15A Activators

Activators in this context would be a class of molecules that specifically increase the activity or function of the LIN-15A protein. These activators would likely have a diverse chemical structure, each designed to interact with the LIN-15A protein in a way that promotes its activity. This interaction could occur through a direct binding event to the LIN-15A protein, perhaps at an active site or an allosteric site, leading to an increase in its natural activity. Alternatively, these activators might bind to other regulatory sites or interact with associated proteins to enhance the activity of LIN-15A indirectly. The design of such molecules would require a deep understanding of the structure and function of LIN-15A, including knowledge of the protein's active sites and the conformational changes necessary for its activation.

In a research setting, scientists would likely use a combination of experimental and computational techniques to study LIN-15A activators. High-throughput screening might be employed to identify initial candidate molecules from large chemical libraries that increase the activity of LIN-15A in cell-based or in vitro assays. Once potential activators are identified, detailed biochemical studies would be conducted to characterize their interaction with LIN-15A. Techniques like surface plasmon resonance (SPR), isothermal titration calorimetry (ITC), or fluorescence-based assays could be used to quantify binding affinities and kinetics. To understand the exact mechanism of activation, structural biology approaches such as X-ray crystallography, NMR spectroscopy, or cryo-electron microscopy might be utilized to visualize the LIN-15A-activator complex at atomic resolution. These studies would reveal how the activator binds to LIN-15A and induces a functional response, providing insights into the fundamental principles governing the activation process.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Famotidine

76824-35-6sc-205691
sc-205691A
500 mg
1 g
$65.00
$111.00
(0)

Manumycin A is a farnesyltransferase inhibitor and may attenuate Ras signaling, potentially leading to a compensatory increase in LIN-15A expression.

Lovastatin

75330-75-5sc-200850
sc-200850A
sc-200850B
5 mg
25 mg
100 mg
$29.00
$90.00
$339.00
12
(1)

Lovastatin inhibits HMG-CoA reductase, possibly affecting protein prenylation and Ras signaling, which could influence LIN-15A expression.

Farnesol

4602-84-0sc-204748
sc-204748A
50 ml
100 ml
$281.00
$374.00
2
(1)

Farnesol is involved in the isoprenoid pathway, which affects Ras signaling. This could indirectly increase LIN-15A expression as a feedback response.

Farnesyl thiosalicylic acid

162520-00-5sc-205322
sc-205322A
1 mg
5 mg
$61.00
$82.00
15
(1)

FTI-277 is a farnesyltransferase inhibitor that may modulate Ras signaling, possibly leading to changes in LIN-15A expression.

Sulindac

38194-50-2sc-202823
sc-202823A
sc-202823B
1 g
5 g
10 g
$32.00
$86.00
$150.00
3
(1)

Sulindac can affect various signaling pathways and may indirectly modify LIN-15A expression through its influence on Ras signaling.

Leflunomide

75706-12-6sc-202209
sc-202209A
10 mg
50 mg
$20.00
$83.00
5
(1)

Leflunomide inhibits dihydroorotate dehydrogenase, which might affect pyrimidine synthesis and Ras signaling, potentially influencing LIN-15A expression.

Mevastatin (Compactin)

73573-88-3sc-200853
sc-200853A
10 mg
50 mg
$77.00
$179.00
18
(1)

Mevastatin is a HMG-CoA reductase inhibitor and may have an impact on Ras signaling pathways, potentially influencing LIN-15A expression.

Zoledronic acid, anhydrous

118072-93-8sc-364663
sc-364663A
25 mg
100 mg
$92.00
$256.00
5
(0)

Zoledronic acid inhibits farnesyl pyrophosphate synthase, which could affect Ras signaling and result in altered LIN-15A expression.